Clarametyx Biosciences, Inc.
2 clinical trials · Sponsor
◉ Watch Clarametyx Biosciences, Inc.
| Record | Firm | Date |
|---|---|---|
| A Study To Evaluate The Safety Of CMTX-101 In People With Cystic Fibrosis (NCT06159725) | Clarametyx Biosciences, Inc. | 2024-06-24 |
| A 2-Part First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of CMTX-101 (NCT05629741) | Clarametyx Biosciences, Inc. | 2022-11-14 |
Track Clarametyx Biosciences, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.